Literature DB >> 3485398

Nifedipine for postoperative blood pressure control following coronary artery vein grafts.

V S Iyer, W J Russell.   

Abstract

The drug control of raised blood pressure following coronary artery bypass grafting was studied in 20 patients during the early postoperative period. On a random basis, 10 patients were given intranasal nifedipine and 10 other patients received intranasal saline. If the systolic pressure was raised, it was treated by an infusion of sodium nitroprusside. The systolic pressure abated in those treated with nifedipine so that 7 of the 10 did not require any other treatment in the first hour. The reduction in pressure was accomplished without an increase in heart rate. The requirement for sodium nitroprusside to control the pressure was much less in the first hour postoperatively in the nifedipine treated group and at 4 hours, the effect of nifedipine was still apparent. This study demonstrates that intranasal nifedipine is an effective adjunct for controlling raised blood pressure in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485398      PMCID: PMC2497818     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  19 in total

1.  Systemic hypertension following myocardial revascularization.

Authors:  F G Estafanous; R C Tarazi; J F Viljoen; M Y el-Tawil
Journal:  Am Heart J       Date:  1973-06       Impact factor: 4.749

2.  Reflexes arising from coronary receptors.

Authors:  A Malliani; A M Brown
Journal:  Brain Res       Date:  1970-12-01       Impact factor: 3.252

3.  Systemic hypertension associated with coronary artery bypass surgery. Predisposing factors, hemodynamic characteristics, humoral profile, and treatment.

Authors:  A J Roberts; A P Niarchos; V A Subramanian; R M Abel; S D Herman; J E Sealey; D B Case; R P White; G A Johnson; J H Laragh; W A Gay
Journal:  J Thorac Cardiovasc Surg       Date:  1977-12       Impact factor: 5.209

Review 4.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Hypertension following coronary artery bypass graft.

Authors:  W McIlvaine; M Boulanger; J G Maillé; B Paiement; J Taillefer; P Sahab
Journal:  Can Anaesth Soc J       Date:  1982-05

6.  Treatment of severe hypertension and hypertensive emergency with nifedipine, a calcium antagonistic agent.

Authors:  N Takekoshi; E Murakami; H Murakami; S Matsui; K Masuya; M Nomura; S Fujita; S Tsuji; T Chatani; J Emoto; H Tsugawa; A Hashimoto
Journal:  Jpn Circ J       Date:  1981-07

7.  Systemic hypertension following myocardial revascularization. A method of treatment using epidural anesthesia.

Authors:  P F Hoar; R F Hickey; D J Ullyot
Journal:  J Thorac Cardiovasc Surg       Date:  1976-06       Impact factor: 5.209

8.  Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.

Authors:  T S Foster; S R Hamann; V R Richards; P J Bryant; D A Graves; R G McAllister
Journal:  J Clin Pharmacol       Date:  1983-04       Impact factor: 3.126

9.  Arterial hypertension in immediate postoperative period after valve replacement.

Authors:  F G Estafanous; R C Tarazi; S Buckley; P C Taylor
Journal:  Br Heart J       Date:  1978-07

Review 10.  Update on calcium-channel blocking agents.

Authors:  R L Talbert; H I Bussey
Journal:  Clin Pharm       Date:  1983 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.